ScoreWhy is Shanghai Shyndec Pharmaceutical Co., Ltd. ?
1
Poor long term growth as Net Sales has grown by an annual rate of -2.62% and Operating profit at 1.93% over the last 5 years
2
Negative results in Dec 25
- OPERATING CASH FLOW(Y) Lowest at CNY 1,166.16 MM
- INVENTORY TURNOVER RATIO(HY) Lowest at 0 times
- RAW MATERIAL COST(Y) Grown by 102.87% (YoY)
3
With ROE of 8.91%, it has a very attractive valuation with a 1.05 Price to Book Value
- Over the past year, while the stock has generated a return of -3.22%, its profits have fallen by -8.9%
- At the current price, the company has a high dividend yield of 2.8
4
Underperformed the market in the last 1 year
- Even though the market (China Shanghai Composite) has generated returns of 22.49% in the last 1 year, the stock has hugely underperformed and has generate negative returns of -3.22% returns
Real-Time Research ReportHow much should you hold?
- Overall Portfolio exposure to Shanghai Shyndec Pharmaceutical Co., Ltd. should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Shanghai Shyndec Pharmaceutical Co., Ltd. for you?
Low Risk, Low Return
Absolute
Risk Adjusted
Volatility
Shanghai Shyndec Pharmaceutical Co., Ltd.
-12.62%
-0.25
18.14%
China Shanghai Composite
13.33%
1.58
14.20%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
-2.62%
EBIT Growth (5y)
1.93%
EBIT to Interest (avg)
20.12
Debt to EBITDA (avg)
0.27
Net Debt to Equity (avg)
-0.32
Sales to Capital Employed (avg)
0.77
Tax Ratio
20.96%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
12.64%
ROE (avg)
10.07%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
12
Industry P/E
Price to Book Value
1.05
EV to EBIT
6.44
EV to EBITDA
4.14
EV to Capital Employed
1.08
EV to Sales
0.88
PEG Ratio
NA
Dividend Yield
2.81%
ROCE (Latest)
16.82%
ROE (Latest)
8.91%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bullish
Bearish
Dow Theory
Mildly Bearish
No Trend
OBV
No Trend
Bullish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend8What is working for the Company
INTEREST COVERAGE RATIO(Q)
The company hardly has any interest cost
NET SALES(Q)
Highest at CNY 4,017.13 MM
-17What is not working for the Company
OPERATING CASH FLOW(Y)
Lowest at CNY 1,166.16 MM
INVENTORY TURNOVER RATIO(HY)
Lowest at 0 times
RAW MATERIAL COST(Y)
Grown by 102.87% (YoY
CASH AND EQV(HY)
Lowest at CNY 4,141.24 MM
DEBT-EQUITY RATIO
(HY)
Highest at 0 %
DEBTORS TURNOVER RATIO(HY)
Lowest at 0 times
DIVIDEND PER SHARE(HY)
Lowest at CNY 0
OPERATING PROFIT MARGIN(Q)
Lowest at 5.24 %
PRE-TAX PROFIT(Q)
At CNY 212.71 MM has Fallen at -34.65%
NET PROFIT(Q)
At CNY 143.21 MM has Fallen at -38.42%
EPS(Q)
Lowest at CNY 0
Here's what is working for Shanghai Shyndec Pharmaceutical Co., Ltd.
Net Sales
At CNY 4,017.13 MM has Grown at 73.92%
over average net sales of the previous four periods of CNY 2,309.79 MMMOJO Watch
Near term sales trend is extremely positive
Net Sales (CNY MM)
Net Sales
Highest at CNY 4,017.13 MM
in the last five periodsMOJO Watch
Near term sales trend is positive
Net Sales (CNY MM)
Here's what is not working for Shanghai Shyndec Pharmaceutical Co., Ltd.
Inventory Turnover Ratio
Lowest at 0 times and Fallen
In each half year in the last five Semi-Annual periodsMOJO Watch
Company's pace of selling inventory has slowed
Inventory Turnover Ratio
Operating Cash Flow
Lowest at CNY 1,166.16 MM
in the last three yearsMOJO Watch
The company's cash revenues from business operations are falling
Operating Cash Flows (CNY MM)
Operating Profit Margin
Lowest at 5.24 %
in the last five periodsMOJO Watch
Company's profit margin has deteriorated
Operating Profit to Sales
Pre-Tax Profit
At CNY 212.71 MM has Fallen at -34.65%
over average net sales of the previous four periods of CNY 325.5 MMMOJO Watch
Near term Pre-Tax Profit trend is negative
Pre-Tax Profit (CNY MM)
Net Profit
At CNY 143.21 MM has Fallen at -38.42%
over average net sales of the previous four periods of CNY 232.57 MMMOJO Watch
Near term Net Profit trend is negative
Net Profit (CNY MM)
EPS
Lowest at CNY 0
in the last five periodsMOJO Watch
Declining profitability; company has created lower earnings for shareholders
EPS (CNY)
Cash and Eqv
Lowest at CNY 4,141.24 MM
in the last six Semi-Annual periodsMOJO Watch
Short Term liquidity is deteriorating
Cash and Cash Equivalents
Debt-Equity Ratio
Highest at 0 %
in the last five Semi-Annual periodsMOJO Watch
The company is borrowing more to fund its operations; it's liquidity situation may be stressed
Debt-Equity Ratio
Debtors Turnover Ratio
Lowest at 0 times
in the last five Semi-Annual periodsMOJO Watch
Company's pace of selling Debtors has slowed
Debtors Turnover Ratio
Dividend per share
Lowest at CNY 0
in the last five yearsMOJO Watch
Company is distributing lower dividend than previous years
DPS (CNY)
Raw Material Cost
Grown by 102.87% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin
Raw Material Cost as a percentage of Sales
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
